Nanosphere's Q4 Revenues More Than Double | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere today reported that its fourth-quarter revenues more than doubled as it nudged ahead of analysts' consensus estimate.

The Northbrook, Ill.-based molecular diagnostics firm reported revenues of $828,000 for the quarter ended Dec. 31, compared to revenues of $310,000 for the fourth quarter of 2010. It beat analysts' expectations for $810,000 in revenues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.